BioMark Diagnostics Correlations
| BMKDF Stock | USD 0.15 0.01 6.25% |
The current 90-days correlation between BioMark Diagnostics and Intelligent Bio Solutions is -0.27 (i.e., Very good diversification). The correlation of BioMark Diagnostics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
BioMark Diagnostics Correlation With Market
Good diversification
The correlation between BioMark Diagnostics and DJI is -0.11 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding BioMark Diagnostics and DJI in the same portfolio, assuming nothing else is changed.
BioMark |
The ability to find closely correlated positions to BioMark Diagnostics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace BioMark Diagnostics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back BioMark Diagnostics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling BioMark Diagnostics to buy it.
Moving together with BioMark Pink Sheet
| 0.83 | TMO | Thermo Fisher Scientific | PairCorr |
| 0.81 | DHR | Danaher | PairCorr |
| 0.61 | LZAGY | Lonza Group AG | PairCorr |
| 0.81 | IDXX | IDEXX Laboratories | PairCorr |
| 0.79 | IQV | IQVIA Holdings | PairCorr |
| 0.65 | MTD | Mettler Toledo Inter | PairCorr |
Moving against BioMark Pink Sheet
| 0.82 | BAC | Bank of America Fiscal Year End 10th of January 2025 | PairCorr |
| 0.81 | DORM | Dorman Products | PairCorr |
| 0.79 | NFLX | Netflix Fiscal Year End 28th of January 2025 | PairCorr |
| 0.79 | PYPL | PayPal Holdings Aggressive Push | PairCorr |
| 0.78 | CRS | Carpenter Technology | PairCorr |
| 0.71 | ET | Energy Transfer LP Aggressive Push | PairCorr |
| 0.62 | GLBE | Global E Online | PairCorr |
| 0.55 | WUXAY | WuXi AppTec Downward Rally | PairCorr |
| 0.54 | BBAI | BigBearai Holdings Tech Boost | PairCorr |
| 0.43 | WUXIF | WuXi AppTec | PairCorr |
| 0.84 | AVTE | Aerovate Therapeutics | PairCorr |
| 0.83 | PLTR | Palantir Technologies Aggressive Push | PairCorr |
| 0.83 | ORCL | Oracle | PairCorr |
| 0.82 | FDP | Fresh Del Monte | PairCorr |
| 0.82 | SOFI | SoFi Technologies | PairCorr |
| 0.81 | MSTR | MicroStrategy Incorporated Buyout Trend | PairCorr |
| 0.8 | FUND | Sprott Focus Trust | PairCorr |
| 0.8 | OPRA | Opera | PairCorr |
| 0.8 | GOOG | Alphabet Class C Aggressive Push | PairCorr |
| 0.79 | IONQ | IONQ Inc | PairCorr |
| 0.72 | BFLY | Butterfly Network | PairCorr |
| 0.71 | 55607PAE5 | MQGAU 5376057 23 | PairCorr |
| 0.66 | LUNR | Intuitive Machines | PairCorr |
| 0.65 | INMD | InMode | PairCorr |
| 0.65 | RUM | Rumble Inc Sell-off Trend | PairCorr |
| 0.57 | SOUN | SoundHound AI Trending | PairCorr |
Related Correlations Analysis
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between BioMark Pink Sheet performing well and BioMark Diagnostics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze BioMark Diagnostics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| STIM | 5.31 | 0.62 | 0.09 | 0.35 | 7.78 | 9.86 | 59.07 | |||
| INBS | 5.05 | 0.06 | (0.01) | 0.41 | 6.04 | 12.00 | 29.81 | |||
| BDSX | 2.60 | (0.35) | 0.00 | 1.95 | 0.00 | 5.66 | 29.19 | |||
| PRPO | 1.96 | (0.10) | 0.00 | 1.77 | 0.00 | 3.85 | 11.81 | |||
| PRPH | 4.43 | (1.65) | 0.00 | 1.69 | 0.00 | 5.73 | 55.04 | |||
| BIAFW | 11.07 | 0.22 | 0.00 | (0.14) | 13.09 | 28.21 | 96.67 | |||
| RDNT | 1.96 | 0.27 | 0.16 | 0.31 | 1.56 | 3.77 | 22.39 | |||
| FONR | 1.49 | (0.18) | 0.00 | (0.10) | 0.00 | 2.15 | 13.29 | |||
| STRR | 2.45 | (0.53) | 0.00 | 4.40 | 0.00 | 5.29 | 17.14 | |||
| QGEN | 1.01 | (0.05) | (0.09) | 0.01 | 1.21 | 2.07 | 4.70 |
Be your own money manager
Our tools can tell you how much better you can do entering a position in BioMark Diagnostics without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Commodity Channel Now
Commodity ChannelUse Commodity Channel Index to analyze current equity momentum |
| All Next | Launch Module |
BioMark Diagnostics Corporate Executives
Elected by the shareholders, the BioMark Diagnostics' board of directors comprises two types of representatives: BioMark Diagnostics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of BioMark. The board's role is to monitor BioMark Diagnostics' management team and ensure that shareholders' interests are well served. BioMark Diagnostics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, BioMark Diagnostics' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Neal Kaplan | CFO of US | Profile |